
Weekend habit enjoyed by millions linked to disorder and risk of deadliest cancer, new study reveals
Obstructive sleep apnoea is a condition that causes repeated pauses in breathing during sleep and extreme snoring—affecting between eight and ten million people in the UK, and up to 30 million Americans.
However researchers have coined the term 'social apnoea' to describe a weekend spike in severity of the problem, linked to lifestyle changes such as alcohol use, smoking and irregular sleep patterns.
The phenomenon was identified by an international team led by Flinders University in Australia, who analysed sleep data from more than 70,000 people worldwide.
Using a clinically validated under-mattress sleep monitor, they found participants were 18 per cent more likely to have moderate to severe apnoea on Saturdays than on Wednesdays.
The condition occurs when the airway repeatedly collapses during sleep, leading to breathing pauses, drops in blood oxygen, disrupted rest and daytime sleepiness.
Untreated, it raises the risk of heart disease, type 2 diabetes, depression, dementia and accidents, due to poor sleep and subsequent tiredness.
Research presented this year at the American Society of Clinical Oncology conference in Chicago also found it significantly increases the risk of deadly lung cancer.
'Sleep apnoea is already a major public health issue, but our findings suggest its true impact may be underestimated,' said lead author Dr Lucia Pinilla, from the Adelaide Institute for Sleep Health at Flinders.
'Most clinical testing is done on a weeknight, missing the weekend effect we're now calling social apnoea.'
The weekend risk was particularly high in men (21 per cent increase versus nine per cent in women) and in under-60s (24 per cent versus seven per cent in over-60s).
Sleeping in for 45 minutes or more on weekends increased the odds of worse apnoea by 47 per cent, and shifting the sleep schedule by more than an hour—dubbed social jetlag—raised it by 38 per cent.
Professor Danny Eckert, Director of FHMRI Sleep Health and senior author, said: 'We don't yet know exactly why, but alcohol use, lighter sleep and less consistent use of OSA therapies likely play a role.'
He recommends maintaining a regular sleep routine, using any prescribed therapy every night—even at weekends—and aiming for the recommended seven to nine hours of sleep.
The weekend effect emerged alongside evidence from a second, related study showing severity also varies by season.
Published in Communications Medicine, the research—led by Dr Bastien Lechat of Flinders—used the same dataset to track changes over 3.5 years across 23 countries.
It found the apnoea-hypopnoea index (AHI)—the measure of breathing interruptions per hour—was up to 19 per cent higher in summer and winter than in spring and autumn in the northern hemisphere, and 10 to 15 per cent higher in summer versus spring in the southern hemisphere.
Higher temperatures were linked to worse apnoea, with nights at 18°C on average producing a 6.4 per cent higher AHI than cooler nights at 6°C.
The researchers believe several factors could be driving these peaks. Hot weather can reduce sleep duration and quality, leading to more light sleep, which is associated with more frequent apnoea events.
In winter, people tend to sleep longer—particularly in the early morning—increasing time in REM sleep, a stage that occurs before and after deep sleep, when apnoea is typically worse.
Sleeping longer than usual by over two hours was linked to a 5.8 per cent increase in AHI, while even shorter sleep than average caused a small rise.
Behavioural changes may also play a part as other research has shown alcohol consumption, weight gain, lower physical activity, and respiratory illnesses all vary seasonally.
The findings from both studies raise questions about how the condition is diagnosed and treated. Most patients have their condition assessed via a single-night sleep study, often during the week.
This, the researchers warn, risks missing important variability—and underestimating severity in some patients.
'A seasonal effect that accounts for around 20 per cent of the variation in AHI is meaningful,' Dr Lechat concluded in his paper.
'Some trials [of OSA treatments] only show modest reductions in severity of 10 to 20 per cent.'
If diagnosis or assessment happens in a low-severity period, he suggests, it could influence treatment decisions.
The studies also suggest the long-standing practice of allowing patients to skip continuous positive airway pressure (CPAP) therapy on weekends may need re-evaluation.
The treatment involves wearing a mask connected to a small machine that delivers a steady stream of air to keep the airway open during sleep—and skipping it could make symptoms worse at the weekend.
For those worried they might have sleep apnoea, common warning signs include loud snoring, choking or gasping during sleep, unrefreshing rest, and excessive daytime fatigue.
Doctors can refer patients for diagnostic testing, which may involve in-lab polysomnography or home-based monitoring.
While the observed fluctuations may not be dramatic for an individual, the authors stress that at a population level, they could have significant implications for health and safety.
Even small increases in severity can raise the risk of cardiovascular events, mental health problems and accidents, especially for people who drive or operate machinery.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Herald Scotland
21 minutes ago
- The Herald Scotland
Mounjaro prices double as weight loss jab popularity soars
A Lilly spokesperson said: 'Following a review, Lilly will increase the UK list price for Mounjaro (tirzepatide) from 1 September to address pricing inconsistencies compared to other developed countries, including in Europe. We have reached an agreement with the NHS to ensure continued supply and patient access." The statement continues: 'While Lilly does not determine the prices that private healthcare providers set, we are working with them to maintain patient access. The UK was one of the first countries where Lilly launched Mounjaro, and our priority was to bring it to patients as quickly as possible during a time of limited supply of GLP-1 RA treatments for type 2 diabetes. 'At launch, Lilly agreed to a UK list price that is significantly below the European average to prevent delays in NHS availability." More than 1.5 million people in the UK are believed to be using weight-loss medication each month, with most buying the jabs from private pharmacies. Mounjaro users report surprising side effect - pharmacists share their tips — Bucks Free Press (@bucksfreepress) August 8, 2025 This comes as the Government has joined forces with Eli Lilly in a bid to tackle obesity. The move could see patients accessing care at pharmacies or by using online platforms. The £85 million programme from Eli Lilly and the Department for Science, Innovation and Technology (DSIT) has been designed to look at how obese patients can access weight management care more easily. This includes through community services, in pharmacies and online. Using these tools, eligible patients could be treated 'in a matter of months', according to Health Secretary Wes Streeting. Under the agreement, the Government will contribute up to £50 million in UK-wide investment. Meanwhile, Eli Lilly will back the programme with £35 million, and NHS organisations will be able to apply for a share of the funding. Recommended reading: Mounjaro warning as pens ruined by heatwave temperatures This comes as users are risking having to throw away perfectly good Mounjaro pens as they have overheated in the recent heatwave. Improper storage of Ozempic, Wegovy and Mounjaro during a heatwave could destroy the active ingredient in these jabs, potentially wiping out their effects entirely, even if the medication looks completely normal. 'We recommend treating your weight-loss pen the same way you'd treat insulin or any critical medication,' says Danielle Brightman, Clinical Director at Numan. 'When in doubt, don't risk it. Speak to a healthcare professional and arrange a replacement.' 8 tips to protect Mounjaro and other weight-loss injections during hot weather Use a medical-grade cool bag. Transport your pen in a proper, insulated container designed for sensitive medications. Don't use improvised ice packs that might freeze the pen by accident. Never leave your pen in hot places. Even 10 minutes in a parked car or on a sunny kitchen counter could expose it to damaging heat if out of its delivery packaging or unrefrigerated. Always check the environment before setting it down. Store below 30°C once in use. Once opened and if not refrigerated, keep your pen in a shaded, ventilated area, away from heat sources, windows, and radiators. If you live in a flat or home without air conditioning, keep the pen in a bedroom or hallway that doesn't heat up from direct sun. Avoid storing near exterior walls if the property retains heat. Follow the usage timeline carefully. The storage instructions between medications. Wegovy after first use can last 6 weeks below 30 degrees then needs to be disposed of, whereas Mounjaro has a shorter time of 30 days below 30 degrees before needing to be disposed of. Stick to that timeframe, and if you're unsure whether it's still safe, consult your provider. Use a fridge thermometer at home. Fridge temperatures can fluctuate, especially in older models or over-packed shelves. A simple digital fridge thermometer can help ensure your pen is always stored between 2–8°C before first use. Planning to travel? Use airline-friendly cooling cases. If you're flying or taking long journeys, consider TSA-approved insulated medication pouches with cooling gel packs. Always store the pen in carry-on luggage, not checked baggage, as cargo holds can get hot or cold. Set storage reminders on your phone. If you're prone to forgetting where you left your pen, set daily reminders to check if it's stored properly, especially during heatwaves or while travelling. Don't store near appliances or steam sources. Keep pens away from kettles, toasters, ovens, dishwashers, and anywhere that might experience sudden heat or humidity, especially in small kitchens or shared spaces. Injections like Ozempic, Wegovy, and Mounjaro are now widely used across the UK for appetite control and sustainable weight management. But despite their growing popularity and increasing availability now through the NHS, most patients don't realise the strict temperature guidelines that must be followed to keep these drugs effective. 'We speak to patients every day who are using GLP-1s for the first time,' says Danielle. 'With temperatures set to soar again this summer, it's crucial we raise awareness about safe medication storage. Heat damage isn't always obvious, but it can have a huge impact on effectiveness and safety."


The Independent
21 minutes ago
- The Independent
Teenager who fatally self-harmed at scandal-hit mental health hospital was unlawfully killed
A teenager who fatally self-harmed at a scandal-hit mental health hospital was unlawfully killed, an inquest jury has ruled. Ruth Szymankiewicz, 14, died on 14 February 2022 after she was left alone at Huntercombe Hospital, also called Taplow Manor, near Maidenhead in Berkshire, despite requiring constant one-to-one observation, Buckinghamshire Coroner's Court was told. Ruth, who had an eating disorder, Tourette syndrome and a tic condition, which had affected her mental health, was left alone for 15 minutes on 12 February, allowing her to make her way to her room, where she self-harmed. She was found and resuscitated before being transferred to John Radcliffe Hospital, but died two days later. During her inquest, it was revealed that the ward she was on was 'severely short-staffed' and missing 'at least half' their workers on the day she self-harmed. In a note written by the teenager before her death, read aloud in court, Ruth criticised the lack of therapy available for patients at the hospital, which she said had an 'unsafe number of staff' and 'should be shut down'. Huntercombe Hospital, Maidenhead, called Taplow Manor, was closed in 2023 following investigations by The Independent revealed accusations of systemic abuse of patients. It was also revealed in court that the care worker responsible for monitoring Ruth had only gone through a day or a day and a half of online training before his first shift at the children 's psychiatric hospital on 12 February 2022. The worker who left her had been working under a fake identity, and police were not able to question him following her death as he fled the country. In a tragic note written by Ruth before her death, read out at the inquest, revealed she had said hospital staff would fall asleep on shift, that there was no access to therapy and that the hospital 'should be shut down'. She said: 'Huntercombe , it doesn't deserve a capital H... It is the shittest mental health institution you could get.. the non-existent therapy, the unsafe number of staff, how the place makes you worse, and the staff literally sleep on their shifts. 'I don't want this to happen to any other patients ever. My suggestion is to shut this place down.' During the inquest, a senior NHS doctor working for the Thames Provider Collaborative, which was responsible for Ruth's admission, admitted that the NHS did not do enough for a 14-year-old who died under the care of a private hospital. Dr Gillian Combes said the NHS was aware the hospital was understaffed daily, that there were concerns over its care, but there were no other choices available that were clinically appropriate for Ruth. Dr Combe, has also warned that children's mental health units across the country are struggling to staff their wards every day and that the NHS does not have the money to build its own wards. Staff working on the unit on the day of her death revealed it was 'severely short-staffed' on the day she self-harmed and was missing around half of the workers it needed that day. A senior nurse and a senior support worker, Michelle Hansey, both revealed that they had raised concerns over short staffing at the hospital to managers before Ruth's death. Ms Hancy told jurors that, on the morning of February 12, she had become 'upset and emotional' because of the insufficient staffing on the Thames ward. 'I have raised (staffing issues) several times before this event,' Ms Hancey said, adding that a lot of staff had fallen sick during that period because of exhaustion. It was also alleged at the inquest that on occasions when the wards were short-staffed staffed Huntercombe managers would look for patients whose observations could be reduced. In 2023, a joint investigation by The Independent and Sky News into a group of hospitals owned by The Huntercombe Group and then taken over by Active Care Group, revealed allegations from children who were at the hospital and their families that they were 'treated like animals' and left traumatised as part of a decade of 'systemic abuse'. Allegations included that patients were subjected to the 'painful' use of restraints and were held down for hours by male nurses. Some were stopped from going outside for months, were living in wards with blood-stained walls, were force-fed and given so much medication that they had become 'zombies'. In 2017, another young girl died at a hospital owned by the Huntercombe Group. Mia Titheridge, 17, who was supposed to be subject to 15-minute observations, took her own life when a nurse failed to check on her for almost an hour, an inquest found. Following The Independent 's reports, the Care Quality Commission stopped new admissions to Taplow Manor, and Active Care Group, which took over its running, later decided to close the hospital.


BBC News
21 minutes ago
- BBC News
Welsh teenager researching medical cannabis to study at Oxford
A teenager who has secured a spot at the University of Oxford says the way cannabis has helped her mother's condition "opened my eyes to its medical potential".Ariana Howells, 17, from Barry in Wales, who achieved three A*s and one A in A-level biology, chemistry, maths, and English literature, plus 97% in her Extended Project Qualification, will now take her place at St Hilda College to study interest in medical cannabis has highlighted the drug's promise, as well as gaps in existing said that despite "stigma and strong media opinions", science was about "being open to where the evidence leads". Ariana, who is a scholarship student at Cardiff Sixth Form College, examined the extent THC, a component of cannabis, can "negatively affect sleep architecture" as part of her studies."There were only seven studies worth citing," Ariana said."I expected clearer answers, but what I found was a real need for more in-depth, unbiased research. "This is something I want to keep exploring at university and beyond."Her mother lives with Crohn's disease, an incurable chronic inflammatory bowel believes medical cannabis has played a crucial role in improving her quality of parents run Cannabis Clinic Cardiff where the teenager has spent the last two years helping with admin and learning about the evolving science behind the plant-based treatment."Seeing my mum's condition and the way cannabis helped her and the patients who visit our clinic really opened my eyes to its medical potential," she said."My dad is also a senior psychiatrist, so I've grown up in a household where science and care come together."Outside of school, she has earned gold in the Biology Olympiad and is a competitive ice preparation for Oxford, Ariana plans to channel her energy into drug development and mental health research, and she is especially interested how medical cannabis could one day transform care."There's still stigma and strong media opinions," she said."But science is about asking difficult questions and being open to where the evidence leads." You can follow BBC Oxfordshire on Facebook, X (Twitter), or Instagram.